Table 4 Cardiac toxicities in patients who received mitoxantrone
Cumulative | LVEF % | ||||
---|---|---|---|---|---|
Patients no. 5 | dose (mg m−2) | Before | After | Prior anthracyclines (mg m−2) | Symptom and sign |
(1) Phase I | 45 | 55 | 40 | Doxo 300 | Asymptomatic |
(2) Phase I | 65 | 55 | 45 | Doxo 280 | Asymptomatic |
(3) Phase II | 20 | 55 | 43 | Epi 480 | Asymptomatic |
(4) Phase II | 40 | 50 | 37 | Epi 480 | Tachycardia |
(5) Phase II | 50 | 60 | 45 | Epi 450 | Asymptomatic |